​

Entera Bio (ENTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ENTX Stock Forecast

Entera Bio (ENTX) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $9.00 and a low of $9.00. This represents a 198.01% increase from the last price of $3.02.

$1 $2 $3 $4 $5 $6 $7 $8 $9 High: $9 Avg: $9 Low: $9 Last Closed Price: $3.02

ENTX Stock Rating

Entera Bio stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

ENTX Price Target Upside V Benchmarks

TypeNameUpside
StockEntera Bio198.01%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-22
Avg Price Target-$9.00$9.00
Last Closing Price$3.02$3.02$3.02
Upside/Downside-198.01%198.01%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26-5---5
Sep, 26-1---1
Aug, 26-1---1
Jul, 26-1---1
Jun, 26-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 18, 2026UBS$9.00$2.99201.00%198.01%
Sep 18, 2026Leerink Partners$9.00$3.03197.03%198.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 24, 2026GuggenheimBuyinitialise
Sep 22, 2026Cantor FitzgeraldOverweightinitialise
Jun 24, 2026H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.47$-0.45$-0.31$-0.25$-0.25-
Avg Forecast$-1.05$-0.49$-0.32$-0.28$-0.55$0.24
High Forecast$-1.05$-0.49$-0.32$-0.28$-0.55$0.24
Low Forecast$-1.05$-0.49$-0.32$-0.28$-0.55$0.24
Surprise %-55.24%-8.16%-3.13%-10.71%-54.55%-

Revenue Forecast

$0 $15M $30M $45M $60M $75M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$571.00K$134.00K-$181.00K$42.00K-
Avg Forecast$543.00K$178.00K$30.00K$139.00K$73.21M$54.58M
High Forecast$543.00K$178.00K$30.00K$139.00K$73.21M$54.58M
Low Forecast$543.00K$178.00K$30.00K$139.00K$73.21M$54.58M
Surprise %5.16%-24.72%-30.22%-99.94%-

Net Income Forecast

$-35M $-26M $-17M $-8M $1M $10M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-12.19M$-13.07M$-8.89M$-9.54M$-11.44M-
Avg Forecast$-30.55M$-8.04M$-9.28M$-8.12M$-15.95M$6.96M
High Forecast$-30.55M$-6.44M$-9.28M$-8.12M$-15.95M$6.96M
Low Forecast$-30.55M$-9.65M$-9.28M$-8.12M$-15.95M$6.96M
Surprise %-60.11%62.49%-4.24%17.47%-28.30%-

ENTX Forecast FAQ

Is Entera Bio stock a buy?

Entera Bio stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Entera Bio is a favorable investment for most analysts.

What is Entera Bio's price target?

Entera Bio's price target, set by 4 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $9 at the low end to $9 at the high end, suggesting a potential 198.01% change from the previous closing price of $3.02.

How does Entera Bio stock forecast compare to its benchmarks?

Entera Bio's stock forecast shows a 198.01% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Entera Bio over the past three months?

  • October 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Entera Bio’s EPS forecast?

Entera Bio's average annual EPS forecast for its fiscal year ending in December 2026 is $0.24, marking a -196.00% decrease from the reported $-0.25 in 2025..

What is Entera Bio’s revenue forecast?

Entera Bio's average annual revenue forecast for its fiscal year ending in December 2026 is $54.58M, reflecting a 129852.38% increase from the reported $42K in 2025.

What is Entera Bio’s net income forecast?

Entera Bio's net income forecast for the fiscal year ending in December 2026 stands at $6.96M, representing a -160.86% decrease from the reported $-11.439M in 2025.